Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study

Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update

(2019) Béla Molnár et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Mutations of key driver genes in colorectal cancer progression and metastasis

(2018) Dongdong Huang et al.   CANCER AND METASTASIS REVIEWS

Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies

(2018) Martha Zavridou et al.   CLINICAL CHEMISTRY

Smad4/DPC4

(2018) Aoife J McCarthy et al.   JOURNAL OF CLINICAL PATHOLOGY

ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress

(2018) Martin H.D. Neumann et al.   Computational and Structural Biotechnology Journal

Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting

(2018) Tanja N. Fehm et al.   CYTOMETRY PART A

The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients

(2017) Francesca Salvianti et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma

(2017) Krittiya Korphaisarn et al.   Oncotarget

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

(2016) C. Alix-Panabieres et al.   Cancer Discovery

Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer

(2016) Francesca De Luca et al.   Oncotarget

Single circulating tumor cell sequencing as an advanced tool in cancer management

(2015) Francesca Salvianti et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Circulating tumor cells

(2014) Cristina Raimondi et al.   CANCER BIOLOGY & THERAPY

FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors

(2014) Denis L. Jardim et al.   PLoS One

Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis

(2013) Cindy Kin et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival

(2013) Christophe Rosty et al.   PLoS One

Disseminated and circulating tumor cells in gastrointestinal oncology

(2011) F.C. Bidard et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents

(2009) J. Tol et al.   ANNALS OF ONCOLOGY

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

(2008) Steven J. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY